SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 199 filers reported holding SEATTLE GENETICS INC in Q2 2013. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $8,032,021,000 | +39.1% | 47,269,424 | -5.6% | 35.43% | -0.4% |
Q1 2020 | $5,775,950,000 | +1.0% | 50,060,240 | +0.0% | 35.57% | +17.0% |
Q4 2019 | $5,719,544,000 | +33.8% | 50,057,277 | 0.0% | 30.41% | +4.6% |
Q3 2019 | $4,274,891,000 | +23.4% | 50,057,277 | 0.0% | 29.08% | +23.5% |
Q2 2019 | $3,464,464,000 | -7.3% | 50,057,277 | -1.9% | 23.54% | -1.6% |
Q1 2019 | $3,738,884,000 | +29.3% | 51,049,760 | +0.0% | 23.93% | +1.1% |
Q4 2018 | $2,892,270,000 | -26.5% | 51,046,060 | 0.0% | 23.68% | -8.7% |
Q3 2018 | $3,936,672,000 | +16.2% | 51,046,060 | 0.0% | 25.93% | +1.8% |
Q2 2018 | $3,388,948,000 | +30.6% | 51,046,060 | +3.0% | 25.46% | +15.8% |
Q1 2018 | $2,594,777,000 | +6.1% | 49,575,409 | +8.4% | 21.99% | +3.7% |
Q4 2017 | $2,446,317,000 | -1.7% | 45,725,556 | 0.0% | 21.20% | +5.1% |
Q3 2017 | $2,487,928,000 | +5.2% | 45,725,556 | 0.0% | 20.18% | -2.5% |
Q2 2017 | $2,365,840,000 | -17.7% | 45,725,556 | +0.0% | 20.68% | -12.0% |
Q1 2017 | $2,873,680,000 | +19.1% | 45,715,556 | +0.0% | 23.52% | -0.6% |
Q4 2016 | $2,412,215,000 | +1.3% | 45,711,856 | +3.7% | 23.65% | +9.4% |
Q3 2016 | $2,381,857,000 | +36.3% | 44,100,294 | +2.0% | 21.61% | +18.0% |
Q2 2016 | $1,747,287,000 | +15.2% | 43,238,967 | +0.0% | 18.32% | +14.5% |
Q1 2016 | $1,517,126,000 | -9.4% | 43,235,267 | +15.9% | 16.00% | +15.4% |
Q4 2015 | $1,673,743,000 | +20.5% | 37,293,728 | +3.5% | 13.87% | +8.0% |
Q3 2015 | $1,389,307,000 | -7.0% | 36,029,746 | +16.7% | 12.84% | -2.1% |
Q2 2015 | $1,494,121,000 | +46.4% | 30,870,262 | +6.9% | 13.11% | +54.4% |
Q1 2015 | $1,020,792,000 | +14.0% | 28,876,712 | +3.6% | 8.49% | -7.1% |
Q4 2014 | $895,197,000 | +7.1% | 27,861,720 | +24.0% | 9.14% | -13.2% |
Q3 2014 | $835,648,000 | -2.8% | 22,475,729 | +0.0% | 10.52% | -0.0% |
Q2 2014 | $859,562,000 | -9.0% | 22,472,229 | +8.4% | 10.53% | -12.3% |
Q1 2014 | $944,887,000 | +14.2% | 20,739,426 | +0.0% | 12.01% | +3.0% |
Q4 2013 | $827,156,000 | -2.3% | 20,735,926 | +7.3% | 11.66% | -3.2% |
Q3 2013 | $846,925,000 | +39.3% | 19,322,947 | 0.0% | 12.04% | +0.1% |
Q2 2013 | $607,900,000 | – | 19,322,947 | – | 12.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |